Suppr超能文献

通过无血清三维培养联合抗癌药物从人骨肉瘤中分离并鉴定癌症干细胞

Isolation and identification of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs.

作者信息

Zhou Song, Li Feng, Xiao Jun, Xiong Wei, Fang Zhong, Chen Wenjian, Niu Pengyan

机构信息

Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

J Huazhong Univ Sci Technolog Med Sci. 2010 Feb;30(1):81-4. doi: 10.1007/s11596-010-0114-4. Epub 2010 Feb 14.

Abstract

The cancer stem cells (CSCs) from human osteosarcoma by serum-free three-dimensional culture combined with anticancer drugs were isolated and identified. The primary cells derived from human osteosarcoma were digested by trypsin to prepare a single-cell suspension, and mixed homogeneously into 1.2% alginate gel. Single-cell alginate gel was cultured with serum-free DMEM/F12 medium. Epirubicin (0.8 microg/mL) was added to the medium to enrich CSCs. After cultured conventionally for 7 to 10 days, most of cells suspended in alginate gel were killed by epirubicin. But few cells survived and some single-cell cloning spheres formed. Immunofluorescent staining for Oct3/4 and Nanog was implemented to find cells with properties of self-renewal and multi-potential differentiation. Cells from cloning spheres were transplanted into BALB/c mice to detect the tumorigenicity in vivo. The results showed that some cells positive for Oct3/4 (TRITC) and Nanog (TRITC) were found in single-cell cloning spheres, and most of positive cells were concentrated in the core of sphere. Cells from spheres could form osteosarcoma in the body of mice. It was concluded that cells from single-cell cloning spheres had the properties of the expression of parts of stem cell genes (Oct3/4 and Nanog), resisting anti-cancer drugs, and tumorigenicity in vivo. To sum up, it is believed that cells obtained from osteosarcoma by serum-free three-dimensional culture combined with anticancer drugs are cancer stem cells.

摘要

采用无血清三维培养结合抗癌药物的方法分离并鉴定了人骨肉瘤癌干细胞(CSCs)。将人骨肉瘤来源的原代细胞用胰蛋白酶消化制备单细胞悬液,均匀混入1.2%的海藻酸钠凝胶中。单细胞海藻酸钠凝胶用无血清DMEM/F12培养基培养。向培养基中加入表柔比星(0.8μg/mL)以富集CSCs。常规培养7至10天后,海藻酸钠凝胶中悬浮的大多数细胞被表柔比星杀死。但有少数细胞存活并形成了一些单细胞克隆球。进行Oct3/4和Nanog的免疫荧光染色以寻找具有自我更新和多能分化特性的细胞。将克隆球中的细胞移植到BALB/c小鼠体内以检测其体内致瘤性。结果显示,在单细胞克隆球中发现了一些Oct3/4(TRITC)和Nanog(TRITC)阳性的细胞,且大多数阳性细胞集中在球的核心。球中的细胞可在小鼠体内形成骨肉瘤。结论是,单细胞克隆球中的细胞具有部分干细胞基因(Oct3/4和Nanog)表达、抗抗癌药物以及体内致瘤性的特性。综上所述,认为通过无血清三维培养结合抗癌药物从骨肉瘤获得的细胞是癌干细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验